[Pharmacoepidemiological registry studies. Personal integrity and the EEC legislation].
作者信息
Wessling A, Bergman U
机构信息
Farmaci/Sortiment, Apoteksbolaget AB, Stockholm.
出版信息
Lakartidningen. 1994 Aug 24;91(34):2976-7.
PMID:7990546
Abstract
摘要
相似文献
1
[Pharmacoepidemiological registry studies. Personal integrity and the EEC legislation].[药物流行病学登记研究。个人诚信与欧共体立法]
Lakartidningen. 1994 Aug 24;91(34):2976-7.
2
[Use of a drug registry. Can asthma be aggravated by tretinoin?].[药物登记系统的使用。维甲酸会加重哮喘吗？]
Lakartidningen. 1994 Aug 24;91(34):2977-8.
3
[National quality registries. Protect or sell out the patients' integrity?].[国家质量登记处。是保护还是出卖患者的权益？]
Lakartidningen. 2011;108(10):521.
4
Pharmacoepidemiology--an Irish perspective.药物流行病学——爱尔兰视角
Pharmacoepidemiol Drug Saf. 2001 Dec;10(7):641-5. doi: 10.1002/pds.640.
5
[A registry for European biologists: why create it?].[欧洲生物学家登记册：为何要创建它？]
Ann Biol Clin (Paris). 1998 May-Jun;56(3):252-3.
6
Databases for pediatric medicine research in Europe--assessment and critical appraisal.欧洲儿科学研究数据库——评估与批判性评价
Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1155-67. doi: 10.1002/pds.1661.
7
Conducting pharmacoepidemiologic research in Denmark.在丹麦开展药物流行病学研究。
Pharmacoepidemiol Drug Saf. 2001 Dec;10(7):619-23. doi: 10.1002/pds.638.
8
The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.欧洲先天性异常登记网络（EUROCAT）用于药物安全监测的潜力：一项描述性研究。
Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):675-82. doi: 10.1002/pds.1265.
9
10
Drug use investigation (DUI) and prescription-event monitoring in Japan (J-PEM).
Pharmacoepidemiol Drug Saf. 2001 Dec;10(7):653-8. doi: 10.1002/pds.642.
Zotero 插件